SCHEMBL30846697

SCHEMBL30846697

Cc1cc(NC(=O)C(C)C2CCCCC2)ccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMARCA2 P51531 1/20 0.47
▸ SMARCA4 P51532 1/20 0.47
▸ SORT1 Q99523 3/20 0.45
▸ ACKR3 P25106 2/20 0.45
▸ PSEN1 P49768 2/20 0.44
▸ PSEN2 P49810 2/20 0.44
▸ APH1B Q8WW43 2/20 0.44
▸ NCSTN Q92542 2/20 0.44
▸ APH1A Q96BI3 2/20 0.44
▸ PSENEN Q9NZ42 2/20 0.44
▸ IDO1 P14902 4/20 0.43
▸ TSHR P16473 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ CYP2C9 P11712 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C8 P10632 1/20 0.42
▸ TDO2 P48775 1/20 0.42
▸ KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30846578 0.99 SMARCA2 (0.48) SMARCA2SMARCA4SORT1ACKR3PSEN1
SCHEMBL30846683 0.85 IDO1 (0.43) IDO1TSHRALDH1A1NPSR1MAPK1
SCHEMBL30846618 0.82 IDO1 (0.46) SORT1IDO1ALDH1A1NPSR1CYP2C9
SCHEMBL16252564 0.78 SMARCA2 (0.58) SMARCA2SMARCA4SORT1PSEN1PSEN2
SCHEMBL20866546 0.77 HTR1E (0.62) TSHRALDH1A1CYP3A4KDM4ESMN1; SMN2
SCHEMBL30846693 0.75 NPC1 (0.58) TSHRALDH1A1CYP3A4KDM4ESMN1; SMN2
SCHEMBL30846735 0.75 RAB9A (0.59) SMARCA2SMARCA4TSHRCYP3A4SMN1; SMN2
SCHEMBL22986541 0.74 IDO1 (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL20838627 0.74 IDO1 (0.64) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30846657 0.73 PRMT3 (0.56) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240116910-A1 Heterocycles as WIP1 Inhibitors PMV PHARMACEUTICALS, INC. 2024-04-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116910-A1 Heterocycles as WIP1 Inhibitors WAPL, WHR1, G3BP1 SMARCA2 316/4885SMARCA4 165/4885SORT1 3106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback